nodes	percent_of_prediction	percent_of_DWPC	metapath
Maprotiline—ABCB1—Methylprednisolone—ankylosing spondylitis	0.105	0.254	CbGbCtD
Maprotiline—ABCB1—Betamethasone—ankylosing spondylitis	0.0685	0.165	CbGbCtD
Maprotiline—ABCB1—Prednisolone—ankylosing spondylitis	0.0676	0.163	CbGbCtD
Maprotiline—ABCB1—Prednisone—ankylosing spondylitis	0.0638	0.154	CbGbCtD
Maprotiline—ABCB1—Dexamethasone—ankylosing spondylitis	0.0398	0.0961	CbGbCtD
Maprotiline—CYP2D6—Dexamethasone—ankylosing spondylitis	0.0375	0.0905	CbGbCtD
Maprotiline—ABCB1—Methotrexate—ankylosing spondylitis	0.032	0.0772	CbGbCtD
Maprotiline—Vision blurred—Prednisolone—ankylosing spondylitis	0.00149	0.00255	CcSEcCtD
Maprotiline—Arrhythmia—Methylprednisolone—ankylosing spondylitis	0.00149	0.00255	CcSEcCtD
Maprotiline—Liver function test abnormal—Methotrexate—ankylosing spondylitis	0.00147	0.00252	CcSEcCtD
Maprotiline—Malnutrition—Methylprednisolone—ankylosing spondylitis	0.00145	0.00248	CcSEcCtD
Maprotiline—Acute coronary syndrome—Prednisone—ankylosing spondylitis	0.00145	0.00248	CcSEcCtD
Maprotiline—Myocardial infarction—Prednisone—ankylosing spondylitis	0.00144	0.00247	CcSEcCtD
Maprotiline—Neuropathy peripheral—Prednisone—ankylosing spondylitis	0.00144	0.00247	CcSEcCtD
Maprotiline—Breast disorder—Methotrexate—ankylosing spondylitis	0.00144	0.00246	CcSEcCtD
Maprotiline—Toxic epidermal necrolysis—Methotrexate—ankylosing spondylitis	0.00144	0.00246	CcSEcCtD
Maprotiline—Dysgeusia—Triamcinolone—ankylosing spondylitis	0.00143	0.00244	CcSEcCtD
Maprotiline—Syncope—Prednisolone—ankylosing spondylitis	0.00142	0.00243	CcSEcCtD
Maprotiline—Eye disorder—Betamethasone—ankylosing spondylitis	0.00142	0.00242	CcSEcCtD
Maprotiline—Eye disorder—Dexamethasone—ankylosing spondylitis	0.00142	0.00242	CcSEcCtD
Maprotiline—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.00139	0.00238	CcSEcCtD
Maprotiline—Angiopathy—Dexamethasone—ankylosing spondylitis	0.00138	0.00235	CcSEcCtD
Maprotiline—Angiopathy—Betamethasone—ankylosing spondylitis	0.00138	0.00235	CcSEcCtD
Maprotiline—Convulsion—Prednisolone—ankylosing spondylitis	0.00137	0.00234	CcSEcCtD
Maprotiline—Hypertension—Prednisolone—ankylosing spondylitis	0.00137	0.00233	CcSEcCtD
Maprotiline—Eosinophilia—Methotrexate—ankylosing spondylitis	0.00137	0.00233	CcSEcCtD
Maprotiline—Arrhythmia—Dexamethasone—ankylosing spondylitis	0.00136	0.00232	CcSEcCtD
Maprotiline—Arrhythmia—Betamethasone—ankylosing spondylitis	0.00136	0.00232	CcSEcCtD
Maprotiline—Alopecia—Betamethasone—ankylosing spondylitis	0.00134	0.00229	CcSEcCtD
Maprotiline—Alopecia—Dexamethasone—ankylosing spondylitis	0.00134	0.00229	CcSEcCtD
Maprotiline—Hallucination—Prednisone—ankylosing spondylitis	0.00131	0.00225	CcSEcCtD
Maprotiline—Pancytopenia—Methotrexate—ankylosing spondylitis	0.00131	0.00224	CcSEcCtD
Maprotiline—Syncope—Triamcinolone—ankylosing spondylitis	0.00131	0.00223	CcSEcCtD
Maprotiline—Syncope—Methylprednisolone—ankylosing spondylitis	0.0013	0.00223	CcSEcCtD
Maprotiline—Oedema—Prednisolone—ankylosing spondylitis	0.00129	0.00221	CcSEcCtD
Maprotiline—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.00128	0.00219	CcSEcCtD
Maprotiline—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.00128	0.00218	CcSEcCtD
Maprotiline—Shock—Prednisolone—ankylosing spondylitis	0.00127	0.00217	CcSEcCtD
Maprotiline—Erectile dysfunction—Methotrexate—ankylosing spondylitis	0.00127	0.00217	CcSEcCtD
Maprotiline—Convulsion—Triamcinolone—ankylosing spondylitis	0.00126	0.00215	CcSEcCtD
Maprotiline—Tachycardia—Prednisolone—ankylosing spondylitis	0.00126	0.00215	CcSEcCtD
Maprotiline—Photosensitivity reaction—Methotrexate—ankylosing spondylitis	0.00126	0.00215	CcSEcCtD
Maprotiline—Convulsion—Methylprednisolone—ankylosing spondylitis	0.00126	0.00215	CcSEcCtD
Maprotiline—Hypertension—Triamcinolone—ankylosing spondylitis	0.00126	0.00215	CcSEcCtD
Maprotiline—Hypertension—Methylprednisolone—ankylosing spondylitis	0.00125	0.00214	CcSEcCtD
Maprotiline—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.00125	0.00213	CcSEcCtD
Maprotiline—Eye disorder—Prednisone—ankylosing spondylitis	0.00123	0.00211	CcSEcCtD
Maprotiline—Anxiety—Methylprednisolone—ankylosing spondylitis	0.00123	0.00211	CcSEcCtD
Maprotiline—Drowsiness—Methotrexate—ankylosing spondylitis	0.00123	0.0021	CcSEcCtD
Maprotiline—Infestation NOS—Methotrexate—ankylosing spondylitis	0.00123	0.0021	CcSEcCtD
Maprotiline—Infestation—Methotrexate—ankylosing spondylitis	0.00123	0.0021	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Methylprednisolone—ankylosing spondylitis	0.00123	0.0021	CcSEcCtD
Maprotiline—Flushing—Prednisone—ankylosing spondylitis	0.00123	0.0021	CcSEcCtD
Maprotiline—Stevens-Johnson syndrome—Methotrexate—ankylosing spondylitis	0.00122	0.00208	CcSEcCtD
Maprotiline—Dry mouth—Triamcinolone—ankylosing spondylitis	0.00121	0.00207	CcSEcCtD
Maprotiline—Stomatitis—Methotrexate—ankylosing spondylitis	0.0012	0.00205	CcSEcCtD
Maprotiline—Angiopathy—Prednisone—ankylosing spondylitis	0.0012	0.00205	CcSEcCtD
Maprotiline—Confusional state—Methylprednisolone—ankylosing spondylitis	0.0012	0.00204	CcSEcCtD
Maprotiline—Oedema—Triamcinolone—ankylosing spondylitis	0.00119	0.00203	CcSEcCtD
Maprotiline—Syncope—Betamethasone—ankylosing spondylitis	0.00118	0.00202	CcSEcCtD
Maprotiline—Syncope—Dexamethasone—ankylosing spondylitis	0.00118	0.00202	CcSEcCtD
Maprotiline—Arrhythmia—Prednisone—ankylosing spondylitis	0.00118	0.00202	CcSEcCtD
Maprotiline—Infection—Triamcinolone—ankylosing spondylitis	0.00118	0.00202	CcSEcCtD
Maprotiline—Infection—Methylprednisolone—ankylosing spondylitis	0.00118	0.00201	CcSEcCtD
Maprotiline—Shock—Triamcinolone—ankylosing spondylitis	0.00117	0.002	CcSEcCtD
Maprotiline—Insomnia—Prednisolone—ankylosing spondylitis	0.00117	0.002	CcSEcCtD
Maprotiline—Alopecia—Prednisone—ankylosing spondylitis	0.00117	0.00199	CcSEcCtD
Maprotiline—Shock—Methylprednisolone—ankylosing spondylitis	0.00117	0.00199	CcSEcCtD
Maprotiline—Hepatobiliary disease—Methotrexate—ankylosing spondylitis	0.00116	0.00199	CcSEcCtD
Maprotiline—Nervous system disorder—Methylprednisolone—ankylosing spondylitis	0.00116	0.00199	CcSEcCtD
Maprotiline—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.00116	0.00198	CcSEcCtD
Maprotiline—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.00116	0.00198	CcSEcCtD
Maprotiline—Paraesthesia—Prednisolone—ankylosing spondylitis	0.00116	0.00198	CcSEcCtD
Maprotiline—Tachycardia—Triamcinolone—ankylosing spondylitis	0.00116	0.00198	CcSEcCtD
Maprotiline—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.00116	0.00198	CcSEcCtD
Maprotiline—Skin disorder—Methylprednisolone—ankylosing spondylitis	0.00115	0.00197	CcSEcCtD
Maprotiline—Malnutrition—Prednisone—ankylosing spondylitis	0.00115	0.00197	CcSEcCtD
Maprotiline—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00115	0.00196	CcSEcCtD
Maprotiline—Agranulocytosis—Methotrexate—ankylosing spondylitis	0.00115	0.00196	CcSEcCtD
Maprotiline—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.00115	0.00196	CcSEcCtD
Maprotiline—Convulsion—Dexamethasone—ankylosing spondylitis	0.00114	0.00196	CcSEcCtD
Maprotiline—Convulsion—Betamethasone—ankylosing spondylitis	0.00114	0.00196	CcSEcCtD
Maprotiline—Hypertension—Dexamethasone—ankylosing spondylitis	0.00114	0.00195	CcSEcCtD
Maprotiline—Hypertension—Betamethasone—ankylosing spondylitis	0.00114	0.00195	CcSEcCtD
Maprotiline—Anxiety—Dexamethasone—ankylosing spondylitis	0.00112	0.00191	CcSEcCtD
Maprotiline—Anxiety—Betamethasone—ankylosing spondylitis	0.00112	0.00191	CcSEcCtD
Maprotiline—Hypotension—Methylprednisolone—ankylosing spondylitis	0.00111	0.00189	CcSEcCtD
Maprotiline—Hepatitis—Methotrexate—ankylosing spondylitis	0.0011	0.00189	CcSEcCtD
Maprotiline—Urinary tract disorder—Methotrexate—ankylosing spondylitis	0.00109	0.00186	CcSEcCtD
Maprotiline—Vision blurred—Prednisone—ankylosing spondylitis	0.00108	0.00185	CcSEcCtD
Maprotiline—Urethral disorder—Methotrexate—ankylosing spondylitis	0.00108	0.00185	CcSEcCtD
Maprotiline—Oedema—Betamethasone—ankylosing spondylitis	0.00108	0.00184	CcSEcCtD
Maprotiline—Oedema—Dexamethasone—ankylosing spondylitis	0.00108	0.00184	CcSEcCtD
Maprotiline—Insomnia—Triamcinolone—ankylosing spondylitis	0.00107	0.00184	CcSEcCtD
Maprotiline—Insomnia—Methylprednisolone—ankylosing spondylitis	0.00107	0.00183	CcSEcCtD
Maprotiline—Infection—Betamethasone—ankylosing spondylitis	0.00107	0.00183	CcSEcCtD
Maprotiline—Infection—Dexamethasone—ankylosing spondylitis	0.00107	0.00183	CcSEcCtD
Maprotiline—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.00107	0.00182	CcSEcCtD
Maprotiline—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.00106	0.00182	CcSEcCtD
Maprotiline—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.00106	0.00182	CcSEcCtD
Maprotiline—Shock—Betamethasone—ankylosing spondylitis	0.00106	0.00181	CcSEcCtD
Maprotiline—Shock—Dexamethasone—ankylosing spondylitis	0.00106	0.00181	CcSEcCtD
Maprotiline—Nervous system disorder—Betamethasone—ankylosing spondylitis	0.00106	0.00181	CcSEcCtD
Maprotiline—Nervous system disorder—Dexamethasone—ankylosing spondylitis	0.00106	0.00181	CcSEcCtD
Maprotiline—Agitation—Prednisone—ankylosing spondylitis	0.00106	0.00181	CcSEcCtD
Maprotiline—Thrombocytopenia—Dexamethasone—ankylosing spondylitis	0.00106	0.0018	CcSEcCtD
Maprotiline—Thrombocytopenia—Betamethasone—ankylosing spondylitis	0.00106	0.0018	CcSEcCtD
Maprotiline—Tachycardia—Betamethasone—ankylosing spondylitis	0.00105	0.0018	CcSEcCtD
Maprotiline—Tachycardia—Dexamethasone—ankylosing spondylitis	0.00105	0.0018	CcSEcCtD
Maprotiline—Dyspepsia—Triamcinolone—ankylosing spondylitis	0.00105	0.00179	CcSEcCtD
Maprotiline—Erythema multiforme—Methotrexate—ankylosing spondylitis	0.00104	0.00178	CcSEcCtD
Maprotiline—Dyspepsia—Methylprednisolone—ankylosing spondylitis	0.00104	0.00178	CcSEcCtD
Maprotiline—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.00104	0.00178	CcSEcCtD
Maprotiline—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.00104	0.00178	CcSEcCtD
Maprotiline—Eye disorder—Methotrexate—ankylosing spondylitis	0.00103	0.00176	CcSEcCtD
Maprotiline—Syncope—Prednisone—ankylosing spondylitis	0.00103	0.00176	CcSEcCtD
Maprotiline—Tinnitus—Methotrexate—ankylosing spondylitis	0.00103	0.00176	CcSEcCtD
Maprotiline—Urticaria—Prednisolone—ankylosing spondylitis	0.00103	0.00175	CcSEcCtD
Maprotiline—Cardiac disorder—Methotrexate—ankylosing spondylitis	0.00102	0.00175	CcSEcCtD
Maprotiline—Fatigue—Triamcinolone—ankylosing spondylitis	0.00102	0.00175	CcSEcCtD
Maprotiline—Fatigue—Methylprednisolone—ankylosing spondylitis	0.00102	0.00175	CcSEcCtD
Maprotiline—Loss of consciousness—Prednisone—ankylosing spondylitis	0.00101	0.00173	CcSEcCtD
Maprotiline—Hypotension—Betamethasone—ankylosing spondylitis	0.00101	0.00172	CcSEcCtD
Maprotiline—Hypotension—Dexamethasone—ankylosing spondylitis	0.00101	0.00172	CcSEcCtD
Maprotiline—Angiopathy—Methotrexate—ankylosing spondylitis	0.001	0.00171	CcSEcCtD
Maprotiline—Convulsion—Prednisone—ankylosing spondylitis	0.000997	0.0017	CcSEcCtD
Maprotiline—Mediastinal disorder—Methotrexate—ankylosing spondylitis	0.000995	0.0017	CcSEcCtD
Maprotiline—Hypertension—Prednisone—ankylosing spondylitis	0.000993	0.0017	CcSEcCtD
Maprotiline—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000979	0.00167	CcSEcCtD
Maprotiline—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000977	0.00167	CcSEcCtD
Maprotiline—Anxiety—Prednisone—ankylosing spondylitis	0.000976	0.00167	CcSEcCtD
Maprotiline—Alopecia—Methotrexate—ankylosing spondylitis	0.000976	0.00167	CcSEcCtD
Maprotiline—Insomnia—Dexamethasone—ankylosing spondylitis	0.000975	0.00167	CcSEcCtD
Maprotiline—Insomnia—Betamethasone—ankylosing spondylitis	0.000975	0.00167	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Prednisone—ankylosing spondylitis	0.000973	0.00166	CcSEcCtD
Maprotiline—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000969	0.00166	CcSEcCtD
Maprotiline—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000968	0.00165	CcSEcCtD
Maprotiline—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000968	0.00165	CcSEcCtD
Maprotiline—Malnutrition—Methotrexate—ankylosing spondylitis	0.000961	0.00164	CcSEcCtD
Maprotiline—Dyspepsia—Betamethasone—ankylosing spondylitis	0.000949	0.00162	CcSEcCtD
Maprotiline—Dyspepsia—Dexamethasone—ankylosing spondylitis	0.000949	0.00162	CcSEcCtD
Maprotiline—Urticaria—Triamcinolone—ankylosing spondylitis	0.000944	0.00161	CcSEcCtD
Maprotiline—Urticaria—Methylprednisolone—ankylosing spondylitis	0.000942	0.00161	CcSEcCtD
Maprotiline—Dysgeusia—Methotrexate—ankylosing spondylitis	0.000941	0.00161	CcSEcCtD
Maprotiline—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000939	0.0016	CcSEcCtD
Maprotiline—Oedema—Prednisone—ankylosing spondylitis	0.000939	0.0016	CcSEcCtD
Maprotiline—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000937	0.0016	CcSEcCtD
Maprotiline—Infection—Prednisone—ankylosing spondylitis	0.000933	0.00159	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Betamethasone—ankylosing spondylitis	0.000931	0.00159	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Dexamethasone—ankylosing spondylitis	0.000931	0.00159	CcSEcCtD
Maprotiline—Fatigue—Betamethasone—ankylosing spondylitis	0.000929	0.00159	CcSEcCtD
Maprotiline—Fatigue—Dexamethasone—ankylosing spondylitis	0.000929	0.00159	CcSEcCtD
Maprotiline—Shock—Prednisone—ankylosing spondylitis	0.000924	0.00158	CcSEcCtD
Maprotiline—Nervous system disorder—Prednisone—ankylosing spondylitis	0.000921	0.00157	CcSEcCtD
Maprotiline—Tachycardia—Prednisone—ankylosing spondylitis	0.000916	0.00157	CcSEcCtD
Maprotiline—Skin disorder—Prednisone—ankylosing spondylitis	0.000912	0.00156	CcSEcCtD
Maprotiline—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000908	0.00155	CcSEcCtD
Maprotiline—Vision blurred—Methotrexate—ankylosing spondylitis	0.000906	0.00155	CcSEcCtD
Maprotiline—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000888	0.00152	CcSEcCtD
Maprotiline—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000888	0.00152	CcSEcCtD
Maprotiline—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000881	0.00151	CcSEcCtD
Maprotiline—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000881	0.00151	CcSEcCtD
Maprotiline—Leukopenia—Methotrexate—ankylosing spondylitis	0.00086	0.00147	CcSEcCtD
Maprotiline—Urticaria—Betamethasone—ankylosing spondylitis	0.000856	0.00146	CcSEcCtD
Maprotiline—Urticaria—Dexamethasone—ankylosing spondylitis	0.000856	0.00146	CcSEcCtD
Maprotiline—Dizziness—Prednisolone—ankylosing spondylitis	0.000854	0.00146	CcSEcCtD
Maprotiline—Asthenia—Triamcinolone—ankylosing spondylitis	0.000852	0.00146	CcSEcCtD
Maprotiline—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000852	0.00146	CcSEcCtD
Maprotiline—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000852	0.00146	CcSEcCtD
Maprotiline—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000852	0.00146	CcSEcCtD
Maprotiline—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000852	0.00146	CcSEcCtD
Maprotiline—Asthenia—Methylprednisolone—ankylosing spondylitis	0.00085	0.00145	CcSEcCtD
Maprotiline—Insomnia—Prednisone—ankylosing spondylitis	0.000849	0.00145	CcSEcCtD
Maprotiline—Paraesthesia—Prednisone—ankylosing spondylitis	0.000843	0.00144	CcSEcCtD
Maprotiline—Pruritus—Triamcinolone—ankylosing spondylitis	0.000841	0.00144	CcSEcCtD
Maprotiline—Pruritus—Methylprednisolone—ankylosing spondylitis	0.000839	0.00143	CcSEcCtD
Maprotiline—Convulsion—Methotrexate—ankylosing spondylitis	0.000833	0.00142	CcSEcCtD
Maprotiline—Dyspepsia—Prednisone—ankylosing spondylitis	0.000826	0.00141	CcSEcCtD
Maprotiline—Rash—Prednisolone—ankylosing spondylitis	0.000815	0.00139	CcSEcCtD
Maprotiline—Dermatitis—Prednisolone—ankylosing spondylitis	0.000814	0.00139	CcSEcCtD
Maprotiline—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—ankylosing spondylitis	0.000813	0.00139	CcSEcCtD
Maprotiline—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000811	0.00139	CcSEcCtD
Maprotiline—Fatigue—Prednisone—ankylosing spondylitis	0.000809	0.00138	CcSEcCtD
Maprotiline—Headache—Prednisolone—ankylosing spondylitis	0.000809	0.00138	CcSEcCtD
Maprotiline—Constipation—Prednisone—ankylosing spondylitis	0.000803	0.00137	CcSEcCtD
Maprotiline—Confusional state—Methotrexate—ankylosing spondylitis	0.000791	0.00135	CcSEcCtD
Maprotiline—Dizziness—Triamcinolone—ankylosing spondylitis	0.000786	0.00134	CcSEcCtD
Maprotiline—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000784	0.00134	CcSEcCtD
Maprotiline—Infection—Methotrexate—ankylosing spondylitis	0.000779	0.00133	CcSEcCtD
Maprotiline—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000774	0.00132	CcSEcCtD
Maprotiline—Asthenia—Betamethasone—ankylosing spondylitis	0.000773	0.00132	CcSEcCtD
Maprotiline—Asthenia—Dexamethasone—ankylosing spondylitis	0.000773	0.00132	CcSEcCtD
Maprotiline—Nervous system disorder—Methotrexate—ankylosing spondylitis	0.000769	0.00131	CcSEcCtD
Maprotiline—Thrombocytopenia—Methotrexate—ankylosing spondylitis	0.000768	0.00131	CcSEcCtD
Maprotiline—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000768	0.00131	CcSEcCtD
Maprotiline—Nausea—Prednisolone—ankylosing spondylitis	0.000767	0.00131	CcSEcCtD
Maprotiline—Pruritus—Betamethasone—ankylosing spondylitis	0.000763	0.0013	CcSEcCtD
Maprotiline—Pruritus—Dexamethasone—ankylosing spondylitis	0.000763	0.0013	CcSEcCtD
Maprotiline—Skin disorder—Methotrexate—ankylosing spondylitis	0.000762	0.0013	CcSEcCtD
Maprotiline—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000758	0.0013	CcSEcCtD
Maprotiline—Vomiting—Triamcinolone—ankylosing spondylitis	0.000755	0.00129	CcSEcCtD
Maprotiline—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000754	0.00129	CcSEcCtD
Maprotiline—Rash—Triamcinolone—ankylosing spondylitis	0.000749	0.00128	CcSEcCtD
Maprotiline—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000748	0.00128	CcSEcCtD
Maprotiline—Rash—Methylprednisolone—ankylosing spondylitis	0.000747	0.00128	CcSEcCtD
Maprotiline—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000747	0.00128	CcSEcCtD
Maprotiline—Urticaria—Prednisone—ankylosing spondylitis	0.000746	0.00127	CcSEcCtD
Maprotiline—Headache—Triamcinolone—ankylosing spondylitis	0.000744	0.00127	CcSEcCtD
Maprotiline—Headache—Methylprednisolone—ankylosing spondylitis	0.000743	0.00127	CcSEcCtD
Maprotiline—Abdominal pain—Prednisone—ankylosing spondylitis	0.000742	0.00127	CcSEcCtD
Maprotiline—Body temperature increased—Prednisone—ankylosing spondylitis	0.000742	0.00127	CcSEcCtD
Maprotiline—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000738	0.00126	CcSEcCtD
Maprotiline—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000738	0.00126	CcSEcCtD
Maprotiline—Hypotension—Methotrexate—ankylosing spondylitis	0.000733	0.00125	CcSEcCtD
Maprotiline—Dizziness—Betamethasone—ankylosing spondylitis	0.000713	0.00122	CcSEcCtD
Maprotiline—Dizziness—Dexamethasone—ankylosing spondylitis	0.000713	0.00122	CcSEcCtD
Maprotiline—Insomnia—Methotrexate—ankylosing spondylitis	0.00071	0.00121	CcSEcCtD
Maprotiline—Nausea—Triamcinolone—ankylosing spondylitis	0.000706	0.00121	CcSEcCtD
Maprotiline—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000704	0.0012	CcSEcCtD
Maprotiline—Nausea—Methylprednisolone—ankylosing spondylitis	0.000704	0.0012	CcSEcCtD
Maprotiline—Somnolence—Methotrexate—ankylosing spondylitis	0.000697	0.00119	CcSEcCtD
Maprotiline—Dyspepsia—Methotrexate—ankylosing spondylitis	0.000691	0.00118	CcSEcCtD
Maprotiline—Vomiting—Betamethasone—ankylosing spondylitis	0.000685	0.00117	CcSEcCtD
Maprotiline—Vomiting—Dexamethasone—ankylosing spondylitis	0.000685	0.00117	CcSEcCtD
Maprotiline—Rash—Dexamethasone—ankylosing spondylitis	0.00068	0.00116	CcSEcCtD
Maprotiline—Rash—Betamethasone—ankylosing spondylitis	0.00068	0.00116	CcSEcCtD
Maprotiline—Dermatitis—Betamethasone—ankylosing spondylitis	0.000679	0.00116	CcSEcCtD
Maprotiline—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000679	0.00116	CcSEcCtD
Maprotiline—Gastrointestinal disorder—Methotrexate—ankylosing spondylitis	0.000677	0.00116	CcSEcCtD
Maprotiline—Fatigue—Methotrexate—ankylosing spondylitis	0.000676	0.00116	CcSEcCtD
Maprotiline—Headache—Dexamethasone—ankylosing spondylitis	0.000675	0.00115	CcSEcCtD
Maprotiline—Headache—Betamethasone—ankylosing spondylitis	0.000675	0.00115	CcSEcCtD
Maprotiline—Asthenia—Prednisone—ankylosing spondylitis	0.000674	0.00115	CcSEcCtD
Maprotiline—Pruritus—Prednisone—ankylosing spondylitis	0.000664	0.00113	CcSEcCtD
Maprotiline—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000647	0.0011	CcSEcCtD
Maprotiline—Diarrhoea—Prednisone—ankylosing spondylitis	0.000642	0.0011	CcSEcCtD
Maprotiline—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000642	0.0011	CcSEcCtD
Maprotiline—Nausea—Dexamethasone—ankylosing spondylitis	0.00064	0.00109	CcSEcCtD
Maprotiline—Nausea—Betamethasone—ankylosing spondylitis	0.00064	0.00109	CcSEcCtD
Maprotiline—Urticaria—Methotrexate—ankylosing spondylitis	0.000623	0.00106	CcSEcCtD
Maprotiline—Dizziness—Prednisone—ankylosing spondylitis	0.000621	0.00106	CcSEcCtD
Maprotiline—Abdominal pain—Methotrexate—ankylosing spondylitis	0.00062	0.00106	CcSEcCtD
Maprotiline—Body temperature increased—Methotrexate—ankylosing spondylitis	0.00062	0.00106	CcSEcCtD
Maprotiline—Vomiting—Prednisone—ankylosing spondylitis	0.000597	0.00102	CcSEcCtD
Maprotiline—Rash—Prednisone—ankylosing spondylitis	0.000592	0.00101	CcSEcCtD
Maprotiline—Dermatitis—Prednisone—ankylosing spondylitis	0.000591	0.00101	CcSEcCtD
Maprotiline—Headache—Prednisone—ankylosing spondylitis	0.000588	0.001	CcSEcCtD
Maprotiline—Asthenia—Methotrexate—ankylosing spondylitis	0.000563	0.000962	CcSEcCtD
Maprotiline—Nausea—Prednisone—ankylosing spondylitis	0.000558	0.000953	CcSEcCtD
Maprotiline—Pruritus—Methotrexate—ankylosing spondylitis	0.000555	0.000948	CcSEcCtD
Maprotiline—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000537	0.000917	CcSEcCtD
Maprotiline—Dizziness—Methotrexate—ankylosing spondylitis	0.000519	0.000886	CcSEcCtD
Maprotiline—Vomiting—Methotrexate—ankylosing spondylitis	0.000499	0.000852	CcSEcCtD
Maprotiline—Rash—Methotrexate—ankylosing spondylitis	0.000495	0.000845	CcSEcCtD
Maprotiline—Dermatitis—Methotrexate—ankylosing spondylitis	0.000494	0.000844	CcSEcCtD
Maprotiline—Headache—Methotrexate—ankylosing spondylitis	0.000491	0.00084	CcSEcCtD
Maprotiline—Nausea—Methotrexate—ankylosing spondylitis	0.000466	0.000796	CcSEcCtD
